Skip to main content

Table 1 Demographic information on the recruited subjects and the indication for the enoxaparin prescription

From: Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium

Demographic

Number N = 123

(%)

Ethnicity

  

Caucasian

66

(54)

African-Caribbean

37

(30)

Asian

9

(7)

Other

11

(9)

Primi gravid

26

(21)

Body mass index (kg/m 2 )

  

Underweight (<18.5)

2

(2)

Normal (18.5-24.9)

62

(50)

Overweight (25-29.9)

32

(26)

Obese Class I (30-34.9)

7

(6)

Obese Class II (35-39.9)

4

(3)

Obese Class III (≥40)

16

(13)

Indication for antenatal enoxaparin

  

Prophylaxis of VTE

83

(68)

Treatment of VTE

9

(7)

Antiphospholipid syndrome

9

(7)

Patients converting from long term warfarin

10

(8)

Other*

12

(10)

  1. *7 patients with recurrent miscarriage in the absence of APLS, 1 patient with a history of retinal artery occlusion, 1 patient with a suspected patent foramen ovale, 1 patient with a history of a stillbirth – histology findings of the placenta reported a perivillous fibrin deposition, placental ageing and dysmaturity, 1 patient with a history of intrauterine growth retardation and abruption, 1 patient with a history of intrauterine growth retardation and pregnancy induced hypertension.